T-cell COVID-19 Atlas | Epsilon GH/452R.V1 (B.1.429+B.1.427)
This strain contains 11 protein-level mutations:
- 4 mutations in Spike protein: S13I, W152C, L452R, D614G
- 1 mutation in N protein: T205I
- 2 mutations in NS3 protein: Q57H, A99V
- 1 mutation in NS9c protein: L52F
- 1 mutation in NSP2 protein: T85I
- 1 mutation in NSP12 protein: P323L
- 1 mutation in NSP13 protein: D260Y
We identified all possible linear viral peptides affected by these mutations. Whenever it was possible, we matched the reference peptide with the mutated one. For example, D -> L mutation transformed SDNGPQNQR to SLNGPQNQR. Cases when it was not meaningful included deletions and insertions at the flanks of the peptide, e.g., HV deletion in NVTWFHAIHV peptide.
Then, we predicted binding affinities between the selected peptides and frequent HLA alleles. Predictions were made with NetMHCpan-4.1 and NetMHCIIpan-4.0. The binding affinities were classifies into three groups:
- Tight binding (IC50 affinity ≤ 50 nM)
- Moderate binding (50 nM < IC50 affinity ≤ 500 nM)
- Weak/no binding (IC50 affinity > 500 nM)
Here we report HLA-peptide interactions whose affinity was altered by at least two folds. Note that mutations with empty set of altered interactions are not showed.
The total number of interactions between HLA-B*27:05 and peptides affected by the mutations
Weaker binding was not found, while stronger binding was found for 7 entries. There are 43 tight binders for the HLA-B*27:05 in the reference immunopeptidome (IC50 affinity ≤ 50 nM); 0 of them became non-tight binders (0.0%) and 3 novel tight binders appeared (6.8%). To avoid possible divisions by zero, we used + 1 regularization term in denominators when calculating percentages.
Download figure Export data to csv
Spike protein L452R
Reference DDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGS ||||||||||||||||||||||||| ||||||||||||||||||||||||| Mutated DDFTGCVIAWNSNNLDSKVGGNYNYRYRLFRKSNLKPFERDISTEIYQAGS
Export table to csv| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-B*27:05 | YLYRLFRK | YRYRLFRK | 9806 | 50 |
| HLA-B*27:05 | YLYRLFRKS | YRYRLFRKS | 13862 | 117 |
| HLA-B*27:05 | YLYRLFRKSNLK | YRYRLFRKSNLK | 2218 | 22 |
| HLA-B*27:05 | YLYRLFRKSNLKP | YRYRLFRKSNLKP | 13004 | 347 |
| HLA-B*27:05 | YLYRLFRKSNLKPF | YRYRLFRKSNLKPF | 7101 | 214 |
| HLA-B*27:05 | YLYRLFRKSNL | YRYRLFRKSNL | 1360 | 48 |
| HLA-B*27:05 | LYRLFRKSNL | RYRLFRKSNL | 932 | 123 |
Từ khóa » Gh/452r.v1
-
Tracking SARS-CoV-2 Variants - WHO | World Health Organization
-
[PDF] WHO Health Emergency Programme
-
[PDF] GISAID – CEPI COVID-19 Update
-
What To Know About SARS-CoV-2 Variants From A Leading ...
-
[PDF] COVID-19 Pandemic
-
Rapid Test & SARS-CoV-2 Variants - CerTest Biotec
-
[PDF] COVID-19 Digest Issue 59 - San Mateo County Health
-
The Ability Of COVID-19 Tests To Detect Emerging Genetic Variants Of ...
-
Evolutionary Traits And Genomic Surveillance Of SARS-CoV-2 In ...
-
Omicron: Understanding The Latest Variant Of SARS‐CoV‐2 And ...
-
Introduction Of SARS‐COV‐2 C.37 (WHO VOI Lambda) From Peru To ...
-
[DOC] S2 Table. - PLOS
-
[PDF] Detection Of SARS-CoV-2 Genomic Variants By Abbott Diagnostic ...